(Asian News Hub) – There is a growing correlation between vaccinated Israelis who have been infected with the Delta variant of SARS-CoV-2 and those who were among the first to get Pfizer’s COVID-19 vaccine, suggesting the vaccine’s protection fades over time, times of israel reported on sunday.
On Thursday, Pfizer said it will seek US authorization for a third dose of its COVID-19 vaccine, saying that another shot within 12 months could boost immunity and maybe help ward off the latest worrisome variants of SARS-CoV-2.
The company’s head of medical research and development, Mikael Dolsten, said in the statement that data from Israel about infections among people vaccinated in January and February indicated that “after six months, there may be risk of infection with the expected decline of antibodies.”
On Sunday, the Yedioth Ahronoth daily published what it said was the Israeli data Dolsten had relied on.
The report said “there is a growing correlation between those who got vaccinated early—mostly in January—and those recently infected.
